Fineface Cream is a topical formulation combining Betamethasone (0.1% w/w), Clindamycin (1% w/w), and Nicotinamide (4% w/w) designed to effectively manage inflammatory and infectious skin conditions. Betamethasone, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing redness, swelling, and itching associated with dermatological disorders. Clindamycin, a lincosamide antibiotic, targets susceptible bacterial infections by inhibiting bacterial protein synthesis, thereby preventing and controlling secondary bacterial infections commonly seen in acne and other inflammatory skin diseases. Nicotinamide, a form of vitamin B3, offers additional anti-inflammatory and skin barrier-enhancing properties, promoting skin hydration and reducing hyperpigmentation. The synergistic action of these three active ingredients makes Fineface Cream suitable for treating acne vulgaris, rosacea, and other inflammatory dermatoses complicated by bacterial colonization. It should be applied as directed by a healthcare professional, typically in a thin layer over the affected area once or twice daily. Caution is advised in prolonged use due to potential corticosteroid-related side effects such as skin thinning. Fineface Cream is intended for external use only and should be avoided in patients with known hypersensitivity to any of its components. Consult a physician before use, especially during pregnancy or lactation.